| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |